Skip to main content
Terug
Watch Compare

Lexaria Bioscience Corp.

Datakwaliteit: 100%
LEXX
Nasdaq Manufacturing Chemicals
€ 0,94
▼ € 0,01 (-1,12%)
Marktkapitalisatie: 23,51 M
Prijs
€ 0,94
Marktkapitalisatie
23,51 M
Dagbereik
€ 0,94 — € 0,99
52-Weeksbereik
€ 0,46 — € 1,69
Volume
60.818
Openen € 0,97
50D / 200D Gem.
€ 0,74
28,19% above
50D / 200D Gem.
€ 0,89
6,67% above

Quick Summary

Belangrijkste Punten

Revenue declined -0,59% annually over 5 years
Negative free cash flow of -8,71 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 52,64%
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
-0,59%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)52,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-206,27%
Onder sectorgemiddelde (-53,41%)
ROIC-172,70%
Net Margin-2067,65%
Op. Margin-2062,00%

Veiligheid

Debt / Equity
N/A
Current Ratio3,68
Interest CoverageN/A

Waardering

PE (TTM)
-2,18
Onder sectorgemiddelde (-1,48)
P/B Ratio4,78
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,2 -1,5
P/B 4,8 1,6
ROE % -206,3 -53,4
Net Margin % -2067,7 -41,5
Rev Growth 5Y % -0,6 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 52,05% Revenue Growth (3Y) 76,65%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -0,59% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 522.000,0 Net Income (TTM) -10,79 M
ROE -206,27% ROA -168,75%
Gross Margin 100,00% Operating Margin -2062,00%
Net Margin -2067,65% Free Cash Flow (TTM) -8,71 M
ROIC -172,70% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,68
Interest Coverage N/A Asset Turnover 0,08
Working Capital 3,91 M Tangible Book Value 4,60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,18 Forward P/E N/A
P/B Ratio 4,78 P/S Ratio 45,03
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37,05%
Market Cap 23,51 M Enterprise Value 19,21 M
Per Share
EPS (Diluted TTM) -0,57 Revenue / Share 0,02
FCF / Share -0,35 OCF / Share -0,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 80,68%
SBC-Adj. FCF -9,52 M Growth Momentum 52,64

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 705.923,0 464.278,0 226.208,0 255.397,0 722.738,0
Net Income -11,90 M -5,80 M -6,66 M -7,27 M -4,19 M
EPS (Diluted) -0,66 -0,47 — — —
Gross Profit 703.203,0 459.456,0 194.708,0 183.556,0 547.392,0
Operating Income -11,88 M -5,75 M -6,53 M -7,38 M —
EBITDA — — — — —
R&D Expenses 8,24 M 2,36 M 3,67 M 1,84 M 1,26 M
SG&A Expenses — — — — —
D&A 51.225,0 76.153,0 145.397,0 102.718,0 —
Interest Expense — 7.760,0 — — —
Income Tax — — — 0,0 6.093,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4,18 M 8,87 M 3,08 M 7,83 M 13,27 M
Total Liabilities 1,57 M 1,21 M 403.908,0 201.437,0 203.265,0
Shareholders' Equity 2,99 M 8,04 M 3,04 M 7,95 M 13,06 M
Total Debt — — — — —
Cash & Equivalents — — — 5,81 M 10,92 M
Current Assets 3,47 M 7,90 M 2,20 M 6,98 M 12,44 M
Current Liabilities 1,49 M 1,10 M 267.735,0 194.036,0 153.276,0